Skip to main content

Table 1 Characteristics of the CLL patients used for flow cytometric analysis

From: Methylome-based cell-of-origin modeling (Methyl-COOM) identifies aberrant expression of immune regulatory molecules in CLL

# of patients

7

Age [years]

57.1 (mean)

52 (median)

Sex

5/7 male

2/7 female

Prior therapies

7/7 no prior treatment

Binet stage

7/7 A

0/7 B

0/7 C

IGHV status

6/7 mutated

1/7 unmutated

Genetics (FISH)

1/7 Trisomy 12

5/7 del(13q)

1/7 no aberration

TP53 mutation status

4/7 WT

3/7 not tested